|
CEP170L expression based on
|
CHOL : Cholangiocarcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
*
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.44209999997091E-06 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.52549999999208E-05 |
| Normal-vs-Stage2 |
1.372250E-02 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
1.035800E-01 |
| Stage1-vs-Stage2 |
9.331000E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
5.689000E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
5.689800E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
*
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.97690000000228E-05 |
| Normal-vs-AfricanAmerican |
2.100400E-01 |
| Normal-vs-Asian |
4.362000E-02 |
| Caucasian-vs-AfricanAmerican |
8.480400E-01 |
| Caucasian-vs-Asian |
8.655000E-01 |
| AfricanAmerican-vs-Asian |
5.156600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
*
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.006100E-04 |
| Normal-vs-Female |
2.642500E-03 |
| Male-vs-Female |
1.667230E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
*
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.719800E-02 |
| Normal-vs-Extreme_Weight |
2.861700E-03 |
| Normal-vs-Obese |
1.806290E-02 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
4.994600E-01 |
| Normal_Weight-vs-Obese |
2.038600E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
4.259000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.645830E-01 |
| Normal-vs-Age(41-60Yrs) |
9.966900E-04 |
| Normal-vs-Age(61-80Yrs) |
2.184000E-03 |
| Normal-vs-Age(81-100Yrs) |
2.818800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.846100E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.263100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.388600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.264200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.347200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.047200E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
7.785600E-01 |
| Normal-vs-Grade 3 |
4.985600E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
2.145200E-01 |
| Grade 2-vs-Grade 4 |
7.785600E-01 |
| Grade 3-vs-Grade 4 |
4.985600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.82440000004747E-06 |
| Normal-vs-N1 |
1.117010E-01 |
| N0-vs-N1 |
3.596800E-01 |
|
|
